Medical innovation in the 1960s produced Oxandrolone, a steroid notable for its low androgenic potential and strong anabolic properties. Marketed as Anavar by G.D. Searle & Co., it was used to aid weight recovery and promote growth in malnourished or post-operative patients. The drug gained broad acceptance in several countries, but its association with non-medical steroid use led to its market exit in 1989. It resurfaced in 1995 when Bio-Technology General Corp. reintroduced it as Oxandrin, now approved only for restricted medical uses under orphan-status protection.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about Oxabull 10 by Bull Pharma, consult with your doctor or healthcare professional.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.